Dr Reddy’s Laboratories Q2 Results: Net profit drops 9.5% to ₹1,342 crore on acquisition cost, revenue up 16.5% YoY
The drugmaker’s total revenue from operations in the second quarter of current fiscal rose 16.5 per cent to ₹8,016 crore.
Yahoo Finance46s
TriplePoint Venture Growth BDC Corp. (TPVG)
MENLO PARK, Calif., October 23, 2024--TriplePoint Venture Growth BDC Corp. (NYSE: TPVG) (the "Company"), the leading financing provider to venture growth stage companies backed by a select group ...